Overview
Citizens Petition
Sponsors
- Sustaining Partners
TUFTS HEALTH CARE INSTITUTE PROGRAM ON OPIOID RISK MANAGEMENT-
Compendium
May 2012-
The Search for an Ideal Analgesic
June 2011-
Pharmacotherapy for Prescription Opioid Addiction
March 2011-
Advancing Safe Opioid Prescribing through Prescriber Training and Behavior Change
June 2010-
Payer Issues Related to Prescription Opioid Monitoring and Abuse
March 2010-
The role of Dentists in Preventing Opioid Abuse
July 2009-
Risk Evaluation and Mitigation Strategy for Prescription Opioids
April 2009-
Prescription Monitoring Research Update
November 2008-
Co-ingestion of Alcohol with Prescription Opioids
June 2008-
The Role of Urine Drug Monitoring in Pain Management
March 2008-
Sources of Diverted Prescription Opioids
September 2007-
Understanding the Types of Opioid Abusers
March 2007-
Responding to Signals of Opioid Abuse
November 2006-
Development of Abuse Deterrent Formulations
September 2006-
Best Practices in Opioid Risk Management
October 2005-
Opioid Abuse Resistance
March 2005-
Opioid Risk Management


Tufts Health Care Institute Program on
Opioid Risk Management

The mission of the Tufts Health Care Institute Program on Opioid Risk Management is to address challenges in the development and utilization of opioid analgesics, by engaging a multidisciplinary group of stakeholders focused on optimizing the benefits of opioid for pain management, and minimizing their risks, including abuse and diversion.

May 4-5, 2012

Agenda

Executive Summary

Overview and purpose of the meeting
Nathaniel Katz, MD, MS Presentation >>

Developing an ideal analgesic: the need now is greater than ever
Frank Vocci, PhD Presentation >>

Keynote address: the historical drive for the search for the ideal analgesic
Nancy Campbell, PhD Presentation >>

Do we still need a better analgesic: public health, public policy, and ethical perspectives
Richard Payne, MD Presentation >>

The origin and history of the National Institutes of Health/College on Problems of Drug Dependence (CPDD) medicines development program: focus on chemistry, lessons for the future
Developed by: Louis Harris, PhD
Presented by: Frank Vocci, PhD Presentation >>

Pre-clinical pharmacology approaches in the NIH Medicines Development Program and lessons for the future
James Woods, PhD Presentation >>

New approaches in the development of opioids and other analgesics
Thomas Prisinzano, PhD Presentation >>

New targets for opioids lacking side-effects
Gavril Pasternak, MD, PhD Presentation >>

A Personal Perspective on Preclinical Drug Development
David Shelton, PhD Presentation >>

Clinical characterization of compounds at the Addiction Research Center
Donald Jasinski, MD Presentation >>

Clinical testing of analgesics: past, present and future
Nathaniel Katz, MD, MS Presentation >>

The current strategy for developing strong non-addictive pain relievers in the pharmaceutical industry
Kenneth Verburg, PhD Presentation >>

Recent progress in grassroots advocacy for addressing the opioid abuse problem
Karen Kelly Presentation >>

NIH Pain Consortium and Translational Medicine Program
Linda Porter, PhD Presentation >>

The FDA ACTTION public-private partnership: what is the FDA doing to accelerate the development of better analgesics?
Robert H. Dworkin, PhD Presentation >>

Legislative update: current efforts to increase federal spending on pain research
Robert Saner, Esq. Presentation >>

 


2008 Tufts Health Care Institute •   Boston, MA 02111 •   (617) 636-1000
Home